Cognate Patient Care Insight Scale

Pilot Study of a New Insight Assessment Tool

Schizophrenia is a disease of young adults that affects 1% of the general population. According to numerous studies, it has been estimated that between 50% and 80% of patients with schizophrenia do not consider to have a mental disorder and are therefore not aware of their disorders. A poor degree of insight is associated with poor compliance, a higher number of re-hospitalizations, altered social and relational functioning, and a higher number of suicides and violent behaviors. This is why insight, which is an essential dimension of psychopathology, must be evaluated, as it depends to a large extent on the therapeutic alliance, adherence to treatment, likelihood of relapse and prognosis.

Evaluation (test, re-test) This new tool for assessing insight will allow for a discrepancy in assessment and a more refined assessment with a view to developing specific care for the patient and / or the relative with regard to the three dimensions Evaluated: disease, treatment and functional implications

Inclusion Criteria:

• Diagnosis of schizophrenia
• Age from 18 to 50 years old
• Stabilized clinical condition (without therapeutic modification during the month prior to inclusion)
• French language read, spoken and understood (patient and family member)
• Having given his consent
• Agreement of the guardian for persons under guardianship
• Consent of the relative

Exclusion Criteria:

• Refusal of patient or legal guardian
• Refusal of the loved one
• Patient and / or neurological disorder of neurological origin of vascular, infectious or neurodegenerative origin